Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Aakash Desai; Vivek Subbiah

doi:10.1002/cncr.34514

Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Aakash Desai, Vivek Subbiah

Investigational Cancer Therapeutics

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Abstract

Immunotherapy has changed the landscape of cancer treatment. However, the benefit of immunotherapy is seen only in some cases, with most patients experiencing cancer progression despite treatment with immunotherapy. To overcome this, combination immunotherapy treatments are being studied. Herein, we propose for a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer.

Original language	English (US)
Pages (from-to)	11-14
Number of pages	4
Journal	Cancer
Volume	129
Issue number	1
DOIs	https://doi.org/10.1002/cncr.34514
State	Published - Jan 1 2023

Keywords

biomarkers
cancer therapy
clinical trials
combination therapy
immunotherapy
precision oncology

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.34514

Cite this

@article{95ce964431ef4165a0fe99dda7d0e13f,

title = "Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy",

abstract = "Immunotherapy has changed the landscape of cancer treatment. However, the benefit of immunotherapy is seen only in some cases, with most patients experiencing cancer progression despite treatment with immunotherapy. To overcome this, combination immunotherapy treatments are being studied. Herein, we propose for a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer.",

keywords = "biomarkers, cancer therapy, clinical trials, combination therapy, immunotherapy, precision oncology",

author = "Aakash Desai and Vivek Subbiah",

note = "Publisher Copyright: {\textcopyright} 2022 American Cancer Society.",

year = "2023",

month = jan,

day = "1",

doi = "10.1002/cncr.34514",

language = "English (US)",

volume = "129",

pages = "11--14",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Rationalizing rules for immunotherapy combination trials

T2 - About time for precision immunotherapy

AU - Desai, Aakash

AU - Subbiah, Vivek

PY - 2023/1/1

Y1 - 2023/1/1

N2 - Immunotherapy has changed the landscape of cancer treatment. However, the benefit of immunotherapy is seen only in some cases, with most patients experiencing cancer progression despite treatment with immunotherapy. To overcome this, combination immunotherapy treatments are being studied. Herein, we propose for a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer.

AB - Immunotherapy has changed the landscape of cancer treatment. However, the benefit of immunotherapy is seen only in some cases, with most patients experiencing cancer progression despite treatment with immunotherapy. To overcome this, combination immunotherapy treatments are being studied. Herein, we propose for a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer.

KW - biomarkers

KW - cancer therapy

KW - clinical trials

KW - combination therapy

KW - immunotherapy

KW - precision oncology

UR - http://www.scopus.com/inward/record.url?scp=85141353153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141353153&partnerID=8YFLogxK

U2 - 10.1002/cncr.34514

DO - 10.1002/cncr.34514

M3 - Editorial

C2 - 36309827

AN - SCOPUS:85141353153

SN - 0008-543X

VL - 129

SP - 11

EP - 14

JO - Cancer

JF - Cancer

IS - 1

ER -

Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this